Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015)
|
|
- Marvin Armstrong
- 6 years ago
- Views:
Transcription
1 Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto BV Hansjörg Toll, Sandoz GmbH March, 2015 The Westin Grand Berlin Berlin, Germany Organized by
2 Table of Contents Program Partners, Exhibitors and Media Partners... Student Travel Grants... Acknowledgements... Scientific Final Program Summary... Session Abstracts... Workshop I Description... Technical Seminar Abstract... Poster Abstracts... 2
3 The Organizing Committee gratefully acknowledges the following program partners for their generous support of this Symposium: Sustaining Platinum Program Partner MedImmune Platinum Program Partners F. Hoffmann - La Roche Ltd. Genedata GmbH Gold Program Partner Bruker Daltonik Exhibitors Agilent Technologies LSG Bruker Daltonik Europa Bioproducts Ltd. Genedata GmbH Genovis AB Postnova Analytics GmbH Protagen Protein Services GmbH ProteinSimple SCIEX Separations, a part of AB SCIEX Thermo Scientific Wyatt Technology Europe 3
4 Media Program Partners The Analytical Scientist BioProcess International Genetic Engineering & Biotechnology News International Pharmaceutical Quality LCGC Europe The Medicine Maker The Pathologist Royal Society of Chemistry separationsnow.com Technology Networks Limited Supporting Organization Gesellschaft Deutscher Chemiker (GDCh) 4
5 CASSS AT Europe Student Travel Grants CASSS is pleased to provide a limited number of student travel grants for PhD students and post-docs who present applicable posters at the inaugural Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2015). PhD students or post-doctoral fellows conducting research at academia throughout the world are eligible. Why you should apply: This Symposium is an active forum for discussion of recent developments and regulatory considerations of the practical application of analytical technologies amongst industry, academia and regulatory agencies. There will be a focus on capillary electrophoresis, mass spectrometry and chromatography for product characterization, process monitoring, formulation development and release testing in the biopharmaceutical industry. As a participant, you will have an excellent opportunity to meet, network and participate in exchanging knowledge for mutual education with your peers. How do you apply: Please send a letter requesting consideration for the grant, a letter of recommendation from your supervisor, proof of your university affiliation and a PDF of your abstract to the Symposium Manager Renee Olson (rolson@casss.org). Application for a travel grant does not release you from the obligation to register and submit your abstract online. Requirements are: - Present a poster on a MS, CE, LC topics relating to Biopharmaceuticals - Proof of studentship/post-doc status - Recommendation from your supervisor The deadline to apply for a student travel grant is Friday, 13 February
6 Social Program Wednesday, 18 March 18:15 19:15 Exhibition Reception Come network and visit exhibitor and posters in the Salon Foyer. Thursday, 19 March 18:30 22:00 Conference Event This event is open to all full conference attendees. One day only attendees will be charged extra to attend. This event will take place at the Kaisersall (Emperor s Saloon) in the Palmenhof and Silbersall rooms. This original venue from 1907 is located in Potsdamer Platz. Postdamer Platz is considered the new city center of Berlin and the former no-man s land. Today this location is considered the connection place between East and West. This is a venue where Past meets the Future and is what Berlin stands for. The event will include a minute tour of Berlin and dinner. 6
7 Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto BV Hansjörg Toll, Sandoz GmbH Acknowledgements Scientific Program Committee: Martin Blüggel, Protagen Protein Services GmbH Francois de l Escaille, Analis s.a./n.v. Christof Finkler, F.Hoffmann La Roche Ltd. Anders Lund, Genzyme, a Sanofi Company Andras Guttman, Northeastern University Birgit Schmauser, BfArM, Federal Institute for Drugs and Medical Devices Harold Taylor, Merz Pharmaceuticlas GmbH Audio-Visual: Michael Johnstone, MJ Audio-Visual Productions CASSS Staff: Stephanie Flores, Executive Director Renee Olson, Senior Program Manager Anna Lingel, Project Coordinator Catherine Stewart, Finance Manager 7
8 AT Europe 2015 Scientific Final Program Summary Tuesday, 17 March, :30 09:00 Buffet Breakfast in Restaurant Coelln 06:30 10:30 Buffet Breakfast in Restaurant Coelln (for accompanying guests) 08:30 14:00 Registration (for course attendees ONLY) in the TBD 09:00 17:00 Short Course in Wintergarten Room Reliable Methods in Capillary Electrophoresis: Fundamentals and Good Working Practice Short Course Facilitators: François de l'escaille, Analis s.a./n.v., Namur, Belgium and Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands 12:30 13:30 Hosted Lunch (for course attendees ONLY) in the Coelln Room 8
9 Wednesday, 18 March, :30 18:00 Registration in the Club Diana 06:30 09:00 Buffet Breakfast in Restaurant Coelln 06:30 10:30 Buffet Breakfast in Restaurant Coelln (for accompanying guests) 09:00 09:05 CASSS Welcome and Introductory Comments in Salon Unter den Linden/Friedrichstadt Frantisek Svec, CASSS President, Emeryville, CA USA 09:05 09:15 Meeting Welcome and Introductory Comments in Salon Unter den Linden/Friedrichstadt Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands Keynote I Session in Salon Unter den Linden/Friedrichstadt Session Chair: Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands 09:15 10:15 Analytical Sciences in Biotechnology: Opportunities and Challenges Wassim Nashabeh, F. Hoffmann La Roche Ltd., Basel, Switzerland 10:15 10:45 Break Visit the Exhibits and Posters the Salon Foyer Interface Development and Quality Control Session in Salon Unter den Linden/Friedrichstadt Session Chair: Harold Taylor, Merz Pharmaceuticals GmbH, Frankfurt Am Main, Germany 10:45 11:10 Charge Heterogeneity by CZE: A Test Method fit for QC Testing? Marc Hassel, Novartis Pharma AG, Basel, Switzerland 11:10 11:35 But It Always Works for ME! R&D vs QC Methods for Biotech Products Nadine Ritter, The Global Biotech Experts Collaborative, LLC, Germantown, MD USA 11:35 12:00 The Regulatory Role of Mass Spectrometry for the Characterization of Peptides, Proteins, and Monoclonal Antibodies Michael Boyne, CDER, FDA, Silver Spring, MD USA (tentative) 12:00 12:30 Discussion 12:30 13:30 Buffet Lunch in Restaurant Coelln 13:30 14:30 Poster Session in Salon Foyer 9
10 Wednesday, 18 March, 2015 New Trends in Capillary Electrophoresis Session in Salon Unter den Linden/Friedrichstadt Session Chair: François de l'escaille, Analis s.a./n.v., Namur, Belgium 14:30 14:55 Development of High-throughput MCE Assays for Classical and Novel Biotherapeutics Friederike Winkhaus, Roche Diagnostics GmbH, Penzberg, Germany 14:55 15:20 Capillary Electrophoresis for the Quantification of Adenovirus Particles for Process Development Support Ewoud van Tricht, Crucell Holland BV, Leiden, The Netherlands 15:20 15:45 Application of Capillary Electrophoresis for the Standardization of Measurements of Protein Biomarkers for In-Vitro Diagnostics Guy Auclair, European Commission, Geel, Belgium 15:45 16:15 Discussion 16:15 17:15 Technical Seminar Expanding the Role of Capillary Electrophoresis Combined with Mass Spectrometry Detection (CE-MS) for the Development, Characterization & Control of Biologics Stephen Lock, SCIEX, Separations, Pudsey, United Kingdom Milla Neffling, AB SCIEX, Warrington, United Kingdom Sponsored by SCIEX Separations Salon Unter den Linden/Friedrichstadt 17:15 18:15 Workshop I: Roud Robin Tabletop Discussion in Salon Unter den Linden/Friedrichstadt Session Chair: Hansjörg Toll, Sandoz GmbH, Kundl, Austria 18:15 19:15 Exhibition Reception Visit the Salon Foyer 10
11 Thursday, 19 March, :30 17:00 Registration in the Club Diana 06:30 09:00 Buffet Breakfast in Restaurant Coelln 06:30 10:30 Buffet Breakfast in Restaurant Coelln (for accompanying guests) Method Development and QbD Session in Salon Unter den Linden/Friedrichstadt Session Chair: Christof Finkler, F. Hoffmann La Roche Ltd., Basel, Switzerland 09:00 09:25 TBD Melissa Hanna-Brown, Pfizer, Inc., Sandwich, UK 09:25 09:50 Quality Aspects in the Research Laboratory - Method Development Katalin Ganzler, Gedeon Richter Plc. Budapest, Hungary 09:50 10:15 TBD Oliver Grosche, Novartis Pharma AG, Basel, Switzerland 10:15 10:45 Discussion 10:45 11:15 Break Visit the Exhibits and Posters in Salon Foyer Post Translational Modification s Session in Salon Unter den Linden/Friedrichstadt Session Chair: András Guttman, Northeastern University, Boston, MA USA 11:15 11:40 CE and UPLC: Complementary High-hand Tools to Tune N-glycosylation of Therapeutic Proteins Ana Krstanovic, Merck Serono, Corsier sur Vevey, Switzerland 11:40 12:05 In Depth Chracterization of Biotherapeutics by Mass Spectrometry - A Case Study Udo Roth, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany 12:05 12:30 Emerging mass spectrometry based methods for therapeutic mabs, biosimilars and ADCs deep structural characterization Elsa Wagner-Rousset, Centre d Immunologie Pierre Fabre, Saint Julien en Genevois, France 12:30 13:00 Discussion 13:00 14:15 Buffet Lunch in Restaurant Coelln 11
12 14:15 14:45 Thursday, 19 March, 2015 Technical Seminar Tackling the Data Analysis Challenge for Deep MS-based Characterization of Biotherapeutics Carsten P. Soenksen, Novo Nordisk Sponsored by Genedata GmbH Salon Unter den Linden/Friedrichstadt New Trends in Mass Spectrometry Session in Salon Unter den Linden/Friedrichstadt Session Chairs: Martin Blüggel, Protagen Protein Services GmbH, Dortmund, Germany 14:45 15:10 New approaches for PK profiling of glycol-variants to support criticality assessment during early development Andreas Seidl, Sandoz Biopharmaceuticals Oberhaching HEXAL AG, Oberhaching, Germany 15:10 15:35 Top-down and Middle-up Hydrogen/deuterium Exchange Mass Spectrometry for Accurate, Sensitive and Comprehensive Structural Characterization of Biosimilars Christoph Borchers, University of Victoria, Victoria, BC Canada 15:35 16:00 Proteomic Characterization of Harvest Cell Culture Fluid in Support of Host Cell Protein Immunoassay Development Christopher Yu, Genentech, a Member of the Roche Group, South San Francisco, CA USA 16:00 16:25 Quantitative Protein Expression Determination for Biologics and Vaccines by Mass Spectrometry Arjen Scholten, Janssen Infectious Diseases and Vaccines Curcell Holland BV, Leiden, The Netherlands 16:25 16:55 Discussion 16:55 17:10 Break - Visit the Exhibits and Posters in Salon Foyer 17:10 18:10 Technical Seminar TBD Sponsored by Bruker Daltonik Salon Unter den Linden/Friedrichstadt 18:30 22:00 Conference Event Location and more information coming soon. 12
13 Friday, 20 March, :30 12:00 Registration in the Club Diana 06:30 09:00 Buffet Breakfast in Restaurant Coelln 06:30 10:30 Buffet Breakfast in Restaurant Coelln (for accompanying guests) CE-MS Session in Salon Unter den Linden/Friedrichstadt Session Chair: Cari Sänger - van de Griend, Kantisto BV, Baarn, The Netherlands 09:00 09:25 Simultaneous Determination of Protein Affinity and Heterogeneity by Capillary Electrophoresis-mass spectrometry Rob Haselberg, VU University, Amsterdam, The Netherlands 09:25 09:50 TBD Göran Hübner, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany 09:50 10:15 In-line-SPE-CE-MS for the Analysis of Glycans and Proteins - Concepts and Recent Results Christian Neusüß, Aalen University, Aalen, Germany 10:15 10:45 Discussion 10:45 11:15 Break - Visit the Exhibits and Posters in Salon Foyer Regulatory Session in Salon Unter den Linden/Friedrichstadt Session Chair: Birgit Schmauser, BfArM, Federal Institute for Drugs and Medical Devices, Bonn, Germany 11:15 11:40 Regulatory Perspectives on Advanced Analytical Methods used for Characterization and Control of Biopharmaceutical Products Sarah Kennett, CDER, FDA, Silver Spring, MD USA 11:40 12:05 Regulatory Interpretation of Characterisation Studies Martijn Van de Plas, CBG-MEB, Utrecht, The Netherlands 12:05 12:35 Discussion 12:35 12:40 Closing Comments in Salon Unter den Linden/Friedrichstadt Hansjörg Toll, Sandoz GmbH, Kundl, Austria 13
Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016)
Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2016) Symposium Co-Chairs: Cari Sänger - van de Griend, Kantisto
More informationAnalytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018)
Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2018) Symposium Co-chairs: Christof Finkler, F. Hoffmann - La
More informationSymposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. David Michels, Genentech, a Member of the Roche Group
CE in the Biotechnology & Pharmaceutical Industries: 19 th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2017) Symposium Co-Chairs: Steffen
More informationAnalytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019)
Analytical Technologies Europe: Symposium on the Practical Applications including CE, LC and MS in the Biopharmaceutical Industry (AT Europe 2019) Symposium Co-chairs: Marta Germano, Janssen Infectious
More informationWelcome to. April 4-5, DoubleTree by Hilton Hotel Silver Spring, MD USA
Welcome to April 4-5, 2016 DoubleTree by Hilton Hotel Silver Spring, MD USA What is CASSS? Practical Applications of Mass Spectrometry EUROPE JAPAN NORTH AMERICA SOUTH AMERICA CASSS is the leading non-profit
More information14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017)
14th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2017) Symposium Co-Chairs: Michael Boyne, BioTechLogic, Inc. Eef Dirksen, Synthon Biopharmaceuticals
More informationWelcome to. January 26, The Mayflower Hotel Washington, DC USA
Welcome to January 26, 2015 The Mayflower Hotel Washington, DC USA Mission Statement Provide a venue for biotechnology/biological product discussion that focuses on relevant CMC issues throughout the lifecycle
More informationSymposium Co-Chairs: Steffen Kiessig, F. Hoffmann La Roche Ltd. Henry Luo, Regeneron Pharmaceuticals, Inc.
CE in the Biotechnology & Pharmaceutical Industries: 18 th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides and Small Molecules (CE Pharm 2016) Symposium Co-Chairs: Steffen
More information12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015)
12th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry (Mass Spec 2015) Symposium Co-Chairs: Steven Cohen, Northeastern University Christopher Yu, Genentech, a
More information7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)
7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) Symposium Co-Chairs: Guodong Chen, Bristol-Myers Squibb Company David Keire, CDER, FDA April 9-11, 2018 Omni Providence
More informationCreating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the
Creating a global community of industry, regulatory and academic professionals to solve scientific and technical problems in order to advance the development of biopharmaceuticals. What is CASSS? CASSS
More informationWelcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade
Welcome to the CMC Strategy Forum Europe 2010: Challenges Facing Biopharmaceutical Development in the Next Decade The fourth annual CMC Strategy Forum Europe, organized by CASSS, An International Separation
More information8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019)
8 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2019) Symposium Co-Chairs: Katherine Bowers, FUJIFILM Diosynth Biotechnologies Guodong Chen, Bristol-Myers Squibb Company
More informationWelcome to the CMC Strategy Forum Europe 2016
Welcome to the CMC Strategy Forum Europe 2016 The 10 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and
More informationWelcome to the CMC Strategy Forum
Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The
More informationWelcome to. January 27, Renaissance Mayflower Hotel Washington, DC USA
Welcome to January 27, 2014 Renaissance Mayflower Hotel Washington, DC USA What is CASSS? MISSION: What We Do CASSS is the global premier, non-profit scientific society facilitating the interaction among
More informationWelcome to December Hotel Okura Tokyo, Japan
Welcome to 9 10 December 2013 Hotel Okura Tokyo, Japan What is CASSS? Non-profit professional membership society that provides networking and peer-to-peer learning opportunities for professionals involved
More information7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018)
7 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2018) Symposium Co-Chairs: Guodong Chen, Bristol-Myers Squibb Company David Keire, CDER, FDA April 9-11, 2018 Omni Providence
More informationWelcome to the CMC Strategy Forum Europe 2016
Welcome to the CMC Strategy Forum Europe 2016 The 10 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and
More informationHigh Potent Medicines Conference
2nd Annual High Potent Medicines Conference Looking beyond scale-up, containment, regulatory aspects and safety of highly potent compounds Event Overview The HPAPI industry is expanding at a healthy rate
More informationHigh Potent Medicines Conference
2nd Annual 2nd Annual MARKETS MARKETSand andmarkets MARKETS High Potent Medicines Conference scale-up, containment, regulatory aspects and safety Main Looking Taunusbeyond Zentrum, Frankfurt, Germany of
More informationWelcome to CMC Strategy Forum Japan 2017
Welcome to CMC Strategy Forum Japan 2017 On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, we would like to extend to you a warm welcome to the second meeting
More informationWelcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward
Welcome to the CMC Strategy Forum Europe 2015 Improving Biopharmaceutical Product Quality: Moving Implementation Forward The ninth annual CMC Strategy Forum Europe, organized by CASSS - An International
More informationWelcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing
Welcome to the CMC Strategy Forum Prior Knowledge: Learning from Our Successes and Failures to Improve Product Development and Manufacturing We are pleased to welcome you to the CMC Strategy Forum. The
More informationWelcome to the CMC Strategy Forum
Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The
More informationPRELIMINARY PROGRAM Bay Area Discussion Group
PRELIMINARY PROGRAM Bay Area Discussion Group Co-chairs: Min Chen, Ultragenyx Pharmaceutical Vinaya Kapoor, Janssen, Pharmaceutical Companies of Johnson & Johnson South San Francisco Conference Center
More informationNortheast Regional Forum
Northeast Regional Forum Accelerated CMC Development Wyndham Boston Beacon Hill 5 Blossom Street Boston, MA 02114 Monday, October 8, 2018 Forum Co-chairs: Francis Poulin, Sanofi Bernice Yeung, Shire Pharmaceuticals
More informationWelcome to CMC Strategy Forum Japan 2015
Welcome to CMC Strategy Forum 2015 On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, we would like to extend to you a warm welcome to the second meeting of
More information4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015)
4 th International Symposium on Higher Order Structure of Protein Therapeutics (HOS 2015) Symposium Co-chairs: Jamie Moore, Genentech, a Member of the Roche Group Linda Narhi, Amgen Inc. April 13-15, 2015
More informationNorthern California Regional Forum
Northern California Regional Forum Cell and Gene Therapies South San Francisco Conference Center South San Francisco, CA Thursday, November 8, 2018 Co-chairs: Nomalie Jaya, Seattle Genetics, Inc. David
More informationTable 1: CE-MS: Unexploited Opportunities in Process Development?
Table 1: CE-MS: Unexploited Opportunities in Process Development? Session 1 Facilitator: Mei Han, Amgen Inc. Scribe: Yunan Wang, Amgen Inc. Session 2 Facilitator: Göran Hübner, Boehringer Ingelheim Pharma
More informationImmunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009
Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Committee Leadership Dr. Ellen Evans (Schering-Plough Research Institute), Chair Dr. Tom Kawabata (Pfizer Inc.), Vice
More informationWelcome to the CMC Strategy Forum Europe 2017
Welcome to the CMC Strategy Forum Europe 2017 The 11 th annual CMC Strategy Forum Europe, organized by CASSS, will explore a number of critical topics focused on improving the quality in development and
More informationThis is not unique to CE. It took for instance about 25 years for HPLC to establish itself properly in the pharmaceutical industry.
CE Pharm 2017 Troubleshooting Report: CZE and CE-SDS the Discussion Continues Workshop facilitators: Tim Blanc 1, Cari Sänger-van de Griend 2 Scribes: Nathan Lacher 3, David Michels 4, Zoran Sosic 5 1
More informationWelcome to the WCBP CMC Strategy Forum
Welcome to the WCBP CMC Strategy Forum We are pleased to welcome you to the 24 th WCBP CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product
More information2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast
2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As
More information2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast
2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As
More informationCE as an analytical tool in industrial biotechnology. David Goodall, CSO, Paraytec Ltd. 14 November Act P x
1 CE as an analytical tool in industrial biotechnology David Goodall, CSO, Paraytec Ltd 14 November 2013 Coverage 2 Modes of CE Industrial sectors for applications Companies and key markets Selected applications
More informationWelcome to the CMC Strategy Forum Latin America 2015
Welcome to the CMC Strategy Forum Latin America 2015 On behalf of the CMC Strategy Forum Global Steering Committee and the CMC Strategy Forum Latin America Scientific Program Committee, we would like to
More informationPurification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences
Chromatography Purification Strategy for Antibodies in partnership with Mannheim University of Applied Sciences Putting theory into practice In today s evolving workplace, it is vital to understand why
More informationThe room was more than 3/4 full with greater than 150 people in attendance.
Summary The room was more than 3/4 full with greater than 150 people in attendance. The questions were well distributed across all four panelists. All the Panelists were very interactive and were able
More informationWorkshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions
Workshop on Cytokine Release: State-of-the-Science, Current Challenges and Future Directions Sponsored by the HESI Immunotoxicology Technical Committee Silver Spring, MD 22 October 2013 Objectives of the
More informationWelcome to the CMC Strategy Forum
Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The
More informationPreliminary Course Program
H3 Africa Program of the National Human Genome Research Institute, NIH, USA, and Welcome Trust, United Kingdom 2015 Proteomics Training Course J Craig Venter Institute, Campus in Rockville, Maryland, October
More informationAdvanced Course Downstream Processing
Advanced Course Downstream Processing 4-8 July, 2016 Aim of the course The aim of the course is to provide and explain the tools to quantitatively and systematically design integrated downstream processes.
More informationWelcome to the CMC Strategy Forum Europe 2018
Welcome to the CMC Strategy Forum Europe 2018 The 12 th annual CMC Strategy Forum Europe, organized by CASSS, will explore many critical topics focused on improving the quality in development and manufacturing
More informationAGENDA Scientist Mentoring & Diversity Program [SMDP Biotech]
AGENDA 2014-2015 Scientist Mentoring & Diversity Program [SMDP Biotech] The International Center for Professional Development and its sponsors will host a training session for the 2014-2015 Scientist Mentoring
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 18 th International Conference on Medicinal and Pharmaceutical Chemistry October 18-19, 2018, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote
More informationWelcome to the CMC Strategy Forum
Welcome to the CMC Strategy Forum We are pleased to welcome you to the CMC Strategy Forum. The purpose of the CMC Strategy Forum is to provide a venue for biotechnology/biological product discussion. The
More informationWelcome to the CMC Strategy Forum Europe 2018
Welcome to the CMC Strategy Forum Europe 2018 The 12 th annual CMC Strategy Forum Europe, organized by CASSS, will explore many critical topics focused on improving the quality in development and manufacturing
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More information2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges Thursday, May 9 Registration Open Continental Breakfast
2019 PDA Biosimilars and Vaccines Conference: Lifecycle Similarities and Challenges End-to-End Product Development Manufacturing, Supply, and Quality May 9-10, 2019 Hilton Long Beach Long Beach, CA As
More informationSHORT COURSE. Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SUNDAY, SEPTEMBER 17
SHORT COURSE SUNDAY, SEPTEMBER 17 OMNI PROVIDENCE HOTEL PROVIDENCE, RI Practical Considerations for Biomarker Bioanalysis: Scientific and Regulatory Perspective SPONSORED BY: Organized by: www.bostonsociety.org
More informationWelcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development
Welcome to the CMC Strategy Forum Phase-appropriate Method Validation Strategies: Policies and Practices to Support Clinical Development We are pleased to welcome you to the CMC Strategy Forum. The purpose
More informationBiochromatography Bring more Zen into your life and laboratory
Seminar Biochromatography Bring more Zen into your life and laboratory Method development and maintaining peptide, protein, glycan and anti-body analyses by LC or LC-MS can be very time consuming and might
More informationCASSS CMC Strategy Forum Barcelona, Spain. EBE Satellite Session Comparability Concept Paper 21 st March 2011
CASSS CMC Strategy Forum Barcelona, Spain EBE Satellite Session Comparability Concept Paper 21 st March 2011 Aim of concept paper Points to consider in planning and undertaking of comparability exercise
More informationModern Approaches to Process Understanding
Biomanufacturing and Process Development (BPD) Modern Approaches to Process Understanding Thursday, September 18, 2014 1:00 pm - Registration begins 1:15 5:00 pm - Presentations & Networking North Carolina
More informationCalendar. The Clear Solution to Reach the Global Biopharma Audience. INTERNATIONAL
The Clear Solution to Reach the Global Biopharma Audience yvdavyd/getty Images & blackred/e+/getty Images 2017 EDITOrial Calendar Editorial Coverage Special Themed Issues January Biopharma Outlook for
More informationThe Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives
The Role of Mass Spectrometry for Developing Biotherapeutics: Regulatory Perspectives Jun Park, Ph.D. Division of Monoclonal Antibodies Office of Biotechnology Products CDER/FDA CASSS, Applications of
More informationCMC Strategy Forum Prague Enda Moran EBE Satellite Session, 06 May 2013
CMC Strategy Forum Prague 2013 Enda Moran EBE Satellite Session, 06 May 2013 European Biopharmaceutical Enterprises EBE s VISION: fostering innovation, and promote favorable business and regulatory conditions
More informationB2B Participation
conferenceseries.com Annual Pharmaceutical Biotechnology Congress May 16-17, 2018 Singapore 200+ 15+ 10+ 50+ 3+ 10+ B2B Participation Interactive Sessions Keynote Lectures Plenary Lectures Workshops Exhibitors
More informationConnecting People, Science and Regulation
Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway, Ste 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm
More informationAdvanced Concepts for Change Control of Analytical Procedures with ICH Q12 Coming
Advanced Concepts for Change Control of Analytical Procedures with ICH Q12 Coming Dr. Jörg Hoffmann / Global Drug Product Governance and CMC Compliance, Merck KGaA (EMD Serono in US) IFPAC Annual Meeting,
More informationPharmacopoeia 2019 PDA EUROPE. The 2 nd Annual PDA Conference on International Developments in the Pharmacopoeial Landscape PEOPLE SCIENCE AND
pda.org/eu/pharma2019 2019 PDA EUROPE Pharmacopoeia The 2 nd Annual PDA Conference on International Developments in the Pharmacopoeial Landscape CONNECTING PEOPLE SCIENCE AND REGULATION 16-17 MAY 2019
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 9 th World Congress on Bioavailability & Bioequivalence April 16-18, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims
More informationEuropean Laboratory Research & Innovation Group PROGRAMME OF EVENTS.
European Laboratory Research & Innovation Group PROGRAMME OF EVENTS www.elrig.org WHO ARE WE? WORLD CLASS MEETINGS & CONFERENCES ELRIG is a UK-based not-for-profit organisation. We are a leader in scientific
More informationPDA Bioburden and Biofilm Workshop
The Parenteral Drug Association presents the... PDA Bioburden and Biofilm Workshop Controlling Microbial Contamination to Assure Product Quality, Patient Safety Save $100 when you register for the workshop
More informationEuropean Bioanalysis Forum
European Bioanalysis Forum Alternative Approaches for Assessment of Drug Neutralizing Activity of ADA Responses Presenter: Arjen Companjen (on behalf of EBF topic team 19) EIP meeting Lisbon 25 February
More informationMODULE 3 Preclinical safety May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES
MODULE 3 Preclinical safety 11-12 May 2016 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES René VERLOES M.D., Ph.D., lecturer in preclinical safety of medicines VUB,
More informationASMS Workshop Report
ASMS Workshop Report 1.Title of workshop and those presiding Title: Get Ready to Become an MS Rising Star -Young Mass Spectrometrists Workshop Presided by Olga Friese (Pfizer) and Dian Su (Genentech) 2.Date
More informationIntelligent Disulfide Bond Analysis
Intelligent Disulfide Bond Analysis Why Study Disulfide Bonds? Save Money by making cell cultures more efficient! Regulations Process Control Higher Quality biotherapeutics Efficacy Protect from Competition
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 10 th International Tissue Repair and Regeneration Congress June 13-14, 2019 Helsinki, Finland our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
More informationFINAL PROGRAM. CASSS Bay Area Discussion Group. Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio
FINAL PROGRAM CASSS Bay Area Discussion Group Co-chairs: Judy Chou, Medivation, Inc. Lance Wong, Strand Bio South San Francisco Conference Center Thursday, October 13, 2016 1 Table of Contents Conference
More informationThe State of QbD in the Biopharmaceutical Industry Conference
The State of QbD in the Biopharmaceutical Industry Conference Criticality Assessment, Design Space Implementation and Control 10 11 April 2013 Sheraton Fisherman s Wharf San Francisco, California USA Sponsored
More informationANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS
ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS ANALYSIS OF AGGREGATES AND PARTICLES IN PROTEIN PHARMACEUTICALS Edited by Hanns-Christian Mahler F. Hoffmann-La Roche Ltd., Basel, Switzerland
More informationPRELIMINARY PROGRAM. Midwest Discussion Group. Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company
PRELIMINARY PROGRAM Midwest Discussion Group Co-chairs: James Carroll, Pfizer, Inc. Kathy Lee, Eli Lilly and Company Eli Lilly and Company Campus June 2, 2016 1 Table of Contents Conference Program Partners..
More informationAnalytical Systems Biology and Characterization of Biotherapeutics
Analytical Systems Biology and Characterization of Biotherapeutics... Overview: Development of protein based medicines is the current burgeoning segment of the global pharmaceutical industry. India has
More informationDRIVE DOWN COSTS. IMPROVE TIMELINES. NAVIGATE THE REGULATORY LANDSCAPE.
26-28 February 2019 Hilton Tokyo Bay Tokyo, Japan DRIVE DOWN COSTS. IMPROVE TIMELINES. NAVIGATE THE REGULATORY LANDSCAPE. BioProcess Experts Help You Accelerate Biologics Development and Production Jerry
More informationCharge Variant Assessment of Nanobodies at the Intact Level by CESI-MS
Charge Variant Assessment of Nanobodies at the Intact Level by CESI-MS Sensitive workflow for the detection of charge variants of nanobodies from small sample volumes Stephen Lock 1, Rob Haselberg 2, Raimond
More informationOctober 6th, 2017 De Doelen - ICC, Rotterdam, The Netherlands
October 6th, 2017 De Doelen - ICC, Rotterdam, The Netherlands The Gold Weigher, Salomon Koninck, 1654 Museum Boijmans van Beuningen, Rotterdam Conference Validation of biomarkers Bridging the innovation
More informationESTIV Second circular and call for abstracts. The 18 th International Congress on In Vitro Toxicology ESTIV2014.
June 10-13, Egmond aan Zee The Netherlands Second circular and call for abstracts The 18 th International Congress on In Vitro Toxicology www.estiv.org 2 Dear Colleague, The European Society of Toxicology
More informationPRELIMINARY AGENDA ** Attendees must already be registered to attend cphi Japan conference**
PRELIMINARY AGENDA ** Attendees must already be registered to attend cphi Japan conference** The Future of Biologics Development and Manufacturing 20 April 2017 13:00 16:00 Big Sight Exhibition Center,
More informationWelcome to CMC Strategy Forum Japan 2018
Welcome to CMC Strategy Forum Japan 2018 On behalf of the CASSS Board of Directors and the CMC Strategy Forum Global Steering Committee, we would like to extend to you a warm welcome to the second meeting
More informationNordic Flow Cytometry Meeting
Nordic Flow Cytometry Meeting 30 31 August and 1 September 2017 Copenhagen, Denmark REGISTRATION Registration to the Nordic Flow Cytometry Meeting starts in December 2016 and includes access to all the
More information9:15 Keynote: Regulatory Perspective on Prior Knowledge Martijn van der Plas, Medicines Evaluation Board
Tuesday, 27 November 2018 16 Nov 2018 9:00 Welcome: Opening Remarks & Introductions Falk Klar, PDA Europe Michael De Felippis, Eli Lilly,, 9:15 Keynote: Regulatory Perspective on Prior Knowledge Session
More informationEXHIBITION & SPONSORSHIP PROSPECTUS DOCUMENT
CENTRE UNIVERSITAIRE DES SAINTS-PÈRES PARIS, 14 16 JUNE 2017 EXHIBITION & SPONSORSHIP PROSPECTUS DOCUMENT TABLE OF CONTENTS 01 01 02 02 SESAM PARIS 2017 ANNUAL MEETING INVITATION TO PARTICIPATE WHAT IS
More informationBDA WORKSHOP PROGRAMME. HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS December 2013 BRUSSELS, BELGIUM
BDA WORKSHOP HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS 12-13 December 2013 BRUSSELS, BELGIUM PROGRAMME BIOTHERAPY DEVELOPMENT ASSOCIATION Content The Biotherapy Development Association
More informationProtein Formulation Development Summit
Summit Register by August 10th and Save up to $200. See page 6 for details! Accelerating your protein therapeutic through analytical characterization, formulation development, delivery device selection
More informationAPV Expert Workshop: The Preformulation Tool Box: The Key to Enter Successful Drug Development
Science based design of formulations and manufacturing processes for oral solid dosage forms from preformulation to capable commercial processes APV Expert Workshop: The Preformulation Tool Box: The Key
More informationCENTRAL NERVOUS SYSTEM (CNS) BIOMARKERS: TECHNOLOGIES AND GLOBAL MARKETS
CENTRAL NERVOUS SYSTEM (CNS) : TECHNOLOGIES AND GLOBAL MARKETS BIO074C March 2016 Jackson Highsmith Project Analyst ISBN: 1-62296-246-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More information9th Open EIP Scientific Symposium. And. Final ABIRISK Open conference. Immunogenicity of Biopharmaceuticals. Draft Program November 2017
9th Open EIP Scientific Symposium And Final ABIRISK Open conference on Immunogenicity of Biopharmaceuticals Draft Program 13-16 November 2017 Altis Hotel Lisbon, Portugal Monday 13th November 2017 EIP
More informationFPO. BioPharma Compass 2.0. Innovation with Integrity. Accelerate Biopharmaceutical Analysis. Software
FPO BioPharma Compass 2.0 Accelerate Biopharmaceutical Analysis Innovation with Integrity Software Developed with the Biopharma Industry Award-winning biopharmaceutical analysis platform Commercial and
More informationSample Attending Companies and Job Titles as of 5 November Attending Companies
Sample Attending Companies and Job Titles as of 5 November 2018 Ajinomoto Co Inc Almac Group Ltd Alnylam Pharmaceuticals Inc Ambiopharm Ardena ChemConnection B V ART BioScience Ascendis Pharma GmbH Aspen
More informationBiotherapeutics Interest Group Workshop 64th ASMS Conference and Allied Topics, June 5 - June 9, 2016, San Antonio, TX
Biotherapeutics Interest Group Workshop 64th ASMS Conference and Allied Topics, June 5 - June 9, 2016, San Antonio, TX Damian Houde, Ph.D. and Ashley Ruth, Ph.D. The Biotherapeutics Interest Group (formerly
More informationThermo Scientific Solutions for Intact-Protein Analysis. Better, Faster Decisions for. Biotherapeutic Development
Thermo Scientific Solutions for Intact-Protein Analysis Better, Faster Decisions for Biotherapeutic Development Quickly and Accurately Assess Product Quality and Safety Therapeutic proteins and monoclonal
More informationPreliminary scientific programme
Preliminary scientific programme November 12, 2018: Day 1 9:00 OPENING WELCOME CEREMONY Session I.: EQUIVALENCE 9:30 What is Equivalence as it Applies to Drug Products Vinod P. Shah Pharmaceutical Consultant,
More informationThe 23 rd Autumn Introductory Course:
The 23 rd Autumn Introductory Course: Target the Heart of European Regulatory Affairs Prague, Czech Republic Sheraton Prague Charles Square hotel Zitna 561/8, Prague 13-17 November 2017 Monday 13 November
More informationNMI Natural and Medical Sciences Institute at the University of Tübingen
NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55, 72770 Reutlingen, Germany GPS-Coordinate: 48 29 38.24 N 9 08 02.73 O AGENDA Get updated about latest developments
More informationBiomarkers and Patient s Access to Personalized Oncology Drugs in Europe
CDDF Cancer Drug Development Forum CDDF MULTI - STAKEHOLDER WORKSHOP Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe Brussels, Belgium 24-25 September 2018 PROGRAMME PROGRAMME
More informationThe Innovative Medicines Initiative
The Innovative Medicines Initiative Innovative funding for biotechs & SMEs in Europe Pierre Meulien, IMI Executive Director BIO-Europe Conference, Copenhagen 06.11.2018 IMI Europe s partnership for health
More information